| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.47 | 0.03 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.41 | 0.04 |